Source: PLOS ONE. Unidade: FCF
Subjects: ZINCO, SELÊNIO, SUPLEMENTAÇÃO ALIMENTAR, DOENÇAS CARDIOVASCULARES
ABNT
EVANGELISTA, Karine Cavalcanti Mauricio Sena et al. The hypolipidemic and pleiotropic effects of rosuvastatin are not enhanced by its association with zinc and selenium supplementation in coronary artery disease patients: a double blind randomized controlled study. PLOS ONE, v. 10, n. 3, p. 1-14, 2015Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0119830. Acesso em: 11 set. 2024.APA
Evangelista, K. C. M. S., Pedrosa, L. de F. C., Paiva, M. S. M. O., Dias, P. C. S., Ferreira, D. Q. C., Cozzolino, S. M. F., et al. (2015). The hypolipidemic and pleiotropic effects of rosuvastatin are not enhanced by its association with zinc and selenium supplementation in coronary artery disease patients: a double blind randomized controlled study. PLOS ONE, 10( 3), 1-14. doi:10.1371/journal.pone.0119830NLM
Evangelista KCMS, Pedrosa L de FC, Paiva MSMO, Dias PCS, Ferreira DQC, Cozzolino SMF, Faulin TES, Abdalla DSP. The hypolipidemic and pleiotropic effects of rosuvastatin are not enhanced by its association with zinc and selenium supplementation in coronary artery disease patients: a double blind randomized controlled study [Internet]. PLOS ONE. 2015 ; 10( 3): 1-14.[citado 2024 set. 11 ] Available from: https://doi.org/10.1371/journal.pone.0119830Vancouver
Evangelista KCMS, Pedrosa L de FC, Paiva MSMO, Dias PCS, Ferreira DQC, Cozzolino SMF, Faulin TES, Abdalla DSP. The hypolipidemic and pleiotropic effects of rosuvastatin are not enhanced by its association with zinc and selenium supplementation in coronary artery disease patients: a double blind randomized controlled study [Internet]. PLOS ONE. 2015 ; 10( 3): 1-14.[citado 2024 set. 11 ] Available from: https://doi.org/10.1371/journal.pone.0119830